Gut bacteria and small-intestine neuroendocrine tumor study
Part of Cancer clinical trials.
This study looks at how bacteria in your gut may affect the growth of small-intestine neuroendocrine tumors. If you are having surgery to remove one of these tumors, the research team will collect samples and data to better understand the link between your gut bacteria and the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a neuroendocrine tumor in your small intestine (the lower part of your bowel)
- You are scheduled to have surgery to remove the tumor
- You are 18 years old or older
- You agree to let the research team use your health information for this study
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether removing the main tumor in the small intestine (along with standard treatment) helps people with small intestinal neuroendocrine tumors that have spread and cannot be cured. It compares this approach to treatment without surgery.
This study looks at how gut bacteria and immune activity differ in normal, pre-cancer, and cancer colon tissue. It may help researchers understand what changes in the body are linked to colon growth and how they could be targeted in the future.
This study looks at how the bacteria in your gut might be linked to brain tumors. Researchers want to collect samples (like stool and tissue) during brain surgery to better understand this connection.
This study looks at how gut bacteria (the microbiome) may differ in children with brain tumors. Researchers will collect samples before and after surgery to understand the connection between gut health and brain tumors.
This study looks at the nutritional health of people with a type of digestive tumor called a neuroendocrine tumor. It aims to understand how these tumors affect nutrition, which could help doctors improve care.
This trial looks at epigenomic markers in different types of neuroendocrine tumors and cancers to find better ways to diagnose and treat them. It may help if you have a neuroendocrine tumor or certain other gastrointestinal cancers that can be surgically removed or biopsied.
Hear when a new Small-intestine Neuroendocrine Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.